KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Amortization of Deferred Charges: 2011-2015

Historic Amortization of Deferred Charges for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to $110,000.

  • Biocryst Pharmaceuticals' Amortization of Deferred Charges changed negligibly% to $110,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $440,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.4 million for FY2020, which is 89.98% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Amortization of Deferred Charges stood at $110,000 for Q4 2015, which was down 0.00% from $110,000 recorded in Q3 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Amortization of Deferred Charges ranged from a high of $110,000 in Q4 2011 and a low of $31,000 during Q1 2011.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $110,000 (2015), whereas its average is $110,000.
  • Data for Biocryst Pharmaceuticals' Amortization of Deferred Charges shows a peak YoY soared of 254.84% (in 2012) over the last 5 years.
  • Over the past 5 years, Biocryst Pharmaceuticals' Amortization of Deferred Charges (Quarterly) stood at $110,000 in 2011, then remained steady at $110,000 in 2012, then remained steady at $110,000 in 2013, then remained steady at $110,000 in 2014, then remained steady at $110,000 in 2015.
  • Its last three reported values are $110,000 in Q4 2015, $110,000 for Q3 2015, and $110,000 during Q2 2015.